Skip to content
Colorectal Cancer Clinical Trials

Ohio

Colorectal cancer clinical trials in Ohio

91 colorectal cancer studies are recruiting participants at sites in 54 cities across Ohio as of November 16, 2026, according to ClinicalTrials.gov.

Call (888) 385-9581
  • No cost to ask
  • Taking part is voluntary
  • Studies are independently reviewed

Browse Ohio by city

Cities with the most studies recruiting right now.

Every Ohio city with a recruiting study

Cleveland (36), Columbus (35), Cincinnati (30), Canton (11), Dayton (7), Franklin (7), Greenville (6), Maumee (6), Toledo (6), Youngstown (6), Centerville (5), West Chester (5), Akron (4), Beavercreek (4), Belpre (4), Boardman (4), Findlay (4), Kettering (4), Mayfield Heights (4), Troy (4), Warren (4), Alliance (3), Marietta (3), Newark (3), Barberton (2), Chillicothe (2), Gahanna (2), Grove City (2), Independence (2), Lancaster (2), Lima (2), Mansfield (2), Marysville (2), Medina (2), Mount Vernon (2), New Albany (2), Perrysburg (2), Portsmouth (2), Sandusky (2), Springfield (2), Strongsville (2), Warrensville Heights (2), Westerville (2), Wooster (2), Zanesville (2), Avon (1), Beachwood (1), Colombus (1), Fairfield (1), Mentor (1), Steubenville (1), Sylvania (1), Westlake (1), Wilmington (1).

The number after each city is how many studies have a recruiting site there. A study with sites in several cities is counted in each one.

Recently updated studies in Ohio

Basic details from each study's public record (the 12 most recently updated of 91). Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.

  1. Testing Pump Chemotherapy in Addition to Standard of Care Chemotherapy Versus Standard of Care Chemotherapy Alone for Patients With Unresectable Colorectal Liver Metastases: The PUMP Trial

    • Phase 3
    • Ages 18 and older
    • All sexes
    Sponsor
    ECOG-ACRIN Cancer Research Group
    Recruiting in
    Columbus · Youngstown
    Registry record
    NCT05863195 · updated
  2. A Study to Investigate the Safety and Preliminary Efficacy of GSK5460025 Alone or in Combination With Other Anti-cancer Agents in Participants With Solid Tumors

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    GlaxoSmithKline
    Recruiting in
    Canton
    Registry record
    NCT07213609 · updated
  3. A Clinical Study of Calderasib (MK-1084) With Targeted Therapy and Chemotherapy in People With Colorectal Cancer (MK-1084-012/KANDLELIT-012)

    • Phase 3
    • Ages 18 and older
    • All sexes
    Sponsor
    Merck Sharp & Dohme LLC
    Recruiting in
    Centerville · Cincinnati · Toledo
    Registry record
    NCT06997497 · updated
  4. A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Colorectal Cancer

    • Phase 2
    • Ages 18 and older
    • All sexes
    Sponsor
    Verastem, Inc.
    Recruiting in
    Cleveland
    Registry record
    NCT07659795 · updated
  5. Neoadjuvant Pembrolizumab and Porustobart in Resectable pMMR/MSS Colon Cancer

    • Phase 2
    • Ages 18 and older
    • All sexes
    Sponsor
    Solstice Oncology, Inc.
    Recruiting in
    Cleveland
    Registry record
    NCT07808151 · updated
  6. Testing the Addition of Anti-cancer Drug, ZEN003694, to the Usual Chemotherapy Treatment, Cetuximab Plus Encorafenib, for Colorectal Cancer

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    National Cancer Institute (NCI)
    Recruiting in
    Columbus
    Registry record
    NCT06102902 · updated
  7. The Vanguard Study: Testing a New Way to Screen for Cancer

    • No phase
    • Ages 45 to 75
    • All sexes
    Sponsor
    National Cancer Institute (NCI)
    Recruiting in
    Cleveland
    Registry record
    NCT06995898 · updated
  8. Evaluating Whether an Educational Website Called Current Together After Cancer (CTAC) Improves Follow-up Care for Colorectal Cancer Survivors

    • Phase 3
    • Ages 18 and older
    • All sexes
    Sponsor
    SWOG Cancer Research Network
    Recruiting in
    Cincinnati
    Registry record
    NCT07018869 · updated
  9. Phase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal Cancer

    • Phase 3
    • Ages 18 and older
    • All sexes
    Sponsor
    Summit Therapeutics
    Recruiting in
    Akron · Canton · Cincinnati · and 2 more U.S. locations
    Registry record
    NCT07228832 · updated
  10. FOLFIRI and Bevacizumab With or Without Pelareorep for Second-Line Treatment of Metastatic RAS-Mutated, Microsatellite-Stable Colorectal Cancer

    • Phase 2
    • Ages 18 and older
    • All sexes
    Sponsor
    Oncolytics Biotech
    Recruiting in
    Canton · Cincinnati · Colombus
    Registry record
    NCT07446322 · updated
  11. Five or Ten Year Colonoscopy for 1-2 Non-Advanced Adenomatous Polyps

    • No phase
    • Ages 45 to 70
    • All sexes
    Sponsor
    NRG Oncology
    Recruiting in
    Beachwood · Centerville · Cincinnati · and 7 more U.S. locations
    Registry record
    NCT05080673 · updated
  12. Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease

    • Phase 2/3
    • Ages 18 and older
    • All sexes
    Sponsor
    NRG Oncology
    Recruiting in
    Akron · Alliance · Avon · and 43 more U.S. locations
    Registry record
    NCT05174169 · updated

Source: ClinicalTrials.gov. Data processed . See every colorectal cancer study recruiting in Ohio on ClinicalTrials.gov.

Ask about studies in Ohio

Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.

How should we reach you?
Add a message or the best time to reach you (optional)

Please do not include detailed medical information.

Before you contact a study

About these listings

These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 16, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded.

Colorectal Cancer Clinical Trials does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.

Sources and further reading

Ask about a study

A coordinator will contact you. Asking does not commit you to anything.

Call (888) 385-9581

or send a short form

How should we reach you?

Call